share_log

圣达生物(603079.SH):万健投资拟减持不超过3%股份

Zhejiang Shengda Bio-Pharm (603079.SH): Wanjian Investment plans to shareholding no more than 3% of its shares.

Gelonghui Finance ·  Dec 27 20:05

Gelonghui reported on December 27 that Zhejiang Shengda Bio-Pharm (603079.SH) announced that Wanjian Investment plans to reduce its shareholding in the company by no more than 5,135,668 shares within three months after 15 trading days from the announcement of this shareholding reduction plan, with a reduction ratio not exceeding 3% of the company's total share capital.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment